Publications by authors named "Einar Hem"

Introduction: New implant designs like the Proximal Femoral Nail Antirotation (PFNA) were developed to reduce failure rates in unstable pertrochanteric fractures in the elderly. Standardized implant augmentation with up to 6 mL of polymethylmethacrylate (PMMA) cement has been introduced to enhance implant anchorage by increasing the implant-bone interface in osteoporotic bone conditions. Biomechanically, loads to failure were significantly higher with augmentation.

View Article and Find Full Text PDF

Background: Angular stable locking of intramedullary nails has been shown to enhance fixation stability of tibial fractures in biomechanical and animal studies. The aim of our study was to assess whether use of the angular stable locking system or conventional locking resulted in earlier full weight-bearing with minimum pain for patients with a distal tibial fracture treated with an intramedullary nail.

Methods: A prospective multicenter, randomized, patient-blinded trial was conducted with adults who had a distal tibial fracture.

View Article and Find Full Text PDF

Background: Few studies have dealt with chronic fatigue (CF) in definitive radiotherapy (RAD) patients during and after (neo-)adjuvant androgen deprivation therapy (ADT) for prostate cancer.

Methods: CF was the primary outcome in this population-based cross-sectional study as evaluated by the Fatigue Questionnaire. We compared the post-RAD levels of fatigue in two groups of > or = 1 year prostate cancer survivors; those with ongoing medical castration (HTcont) and those who had used a luteinizing hormone-releasing hormone analog (LHRHa), but had discontinued the therapy at the time of the survey (HTdis).

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on evaluating cancer patient management in Norway, specifically for prostate cancer diagnosed in 2004, using the EAU guidelines as a framework.
  • Data from the Norwegian Prostate Cancer Registry shows a 96% compliance rate, with the majority of patients having non-metastatic T1-T3 tumors, while a smaller subset had advanced disease.
  • Among the candidates for curative treatment, a significant portion received radical prostatectomy or radiotherapy, but only 64% of intermediate/high-risk patients received local treatments, highlighting disparities in treatment approaches based on risk levels.
View Article and Find Full Text PDF